Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036579 · ClinicalTrials.gov registry record · NA
Celtra Duo Computer Assisted Design/Computer Assisted Machining (CAD/CAM) Dental Crown Study
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT03036579: Clinical Trial NA study, sponsored by University of Michigan.
NCT03036579 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 73 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03036579, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
This investigation will be a clinical trial to study the performance of a newly developed high strength ceramic material for crowns. The ceramic has been approved by the FDA for patient treatment. A computer technique will be used to fabricate the crowns in a single appointment without the need for a temporary crown or second appointment. Two adhesive resin cement techniques will be used to hold the crown to the tooth and they will be evaluated for creating sensitivity to the tooth. The purpose of the study is to measure how well the high strength crowns function over an extended period of time.
Primary Outcome
Crown failure includes fracture of the crown or loss of the crown requiring placement of a new crown at any time between delivery and three years.
Interventions
- DEVICE Celtra Duo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-09 |
| Phase | NA |
Why NCT03036579 stopped before completion
NCT03036579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Celtra Duo is the first listed.
NCT03036579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03036579 about?
NCT03036579 is a clinical study titled "Celtra Duo Computer Assisted Design/Computer Assisted Machining (CAD/CAM) Dental Crown Study". This investigation will be a clinical trial to study the performance of a newly developed high strength ceramic material for crowns. The ceramic has been approved by the FDA for patient treatment. A computer technique will be used to fabricate the crowns in a single appointment without the need for ...
What is the current status of trial NCT03036579?
This trial is currently terminated. It is a NA study. The enrollment target is 73 participants. The study started on 2015-11. Estimated completion is 2019-09.
What interventions are being tested in trial NCT03036579?
The interventions under investigation include: Celtra Duo (DEVICE).
Who is sponsoring clinical trial NCT03036579?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03036579's enrollment target sits among peer trials
73 1089th of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia